MSFP
GMAB icon

Mark Sheptoff Financial Planning’s Genmab GMAB Stock Holding History

Mark Sheptoff Financial Planning’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,400
Closed -$43.1K – 539
2025
Q4 		$43.1K Hold
1,400
– – 0.02% 206
2025
Q3 		$42.9K Hold
1,400
– – 0.02% 201
2025
Q2 		$28.9K Hold
1,400
– – 0.02% 231
2025
Q1 		$27.4K Hold
1,400
– – 0.02% 217
2024
Q4 		$29.2K Hold
1,400
– – 0.02% 221
2024
Q3 		$34.1K Hold
1,400
– – 0.02% 199
2024
Q2 		$35.2K Hold
1,400
– – 0.02% 204
2024
Q1 		$41.9K Hold
1,400
– – 0.02% 184
2023
Q4 		$44.6K Sell
1,400
-700
-33% -$22K 0.03% 171
2023
Q3 		$74.1K Hold
2,100
– – 0.05% 123
2023
Q2 		$79.8K Hold
2,100
– – 0.05% 130
2023
Q1 		$79.3K Hold
2,100
– – 0.05% 129
2022
Q4 		$89K Hold
2,100
– – 0.05% 121
2022
Q3 		$67K Hold
2,100
– – 0.04% 127
2022
Q2 		$68K Hold
2,100
– – 0.04% 139
2022
Q1 		$76K Hold
2,100
– – 0.04% 147
2021
Q4 		$83K Hold
2,100
– – 0.04% 145
2021
Q3 		$92K Buy
2,100
+300
+17% +$13.5K 0.05% 143
2021
Q2 		$73K Sell
1,800
-500
-22% -$19.3K 0.04% 156
2021
Q1 		$76K Sell
2,300
-700
-23% -$26.3K 0.04% 136
2020
Q4 		$122K Sell
3,000
-400
-12% -$15K 0.07% 122
2020
Q3 		$124K Buy
3,400
+200
+6% +$7.23K 0.08% 113
2020
Q2 		$108K Buy
+3,200
New +$87.2K 0.07% 115

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Mark Sheptoff Financial Planning's GMAB Position: Q1 2026 in Review

Mark Sheptoff Financial Planning sold out of Genmab (GMAB) in Q1 2026, closing a stake of 1,400 shares — an estimated $43.1K sold.

Mark Sheptoff Financial Planning first reported a position in GMAB in Q2 2020 and held it in 23 quarters. The position peaked at $124K in Q3 2020. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Mark Sheptoff Financial Planning reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Mark Sheptoff Financial Planning sold 1,400 Genmab shares in Q1 2026, an estimated $43.1K.
  • Mark Sheptoff Financial Planning first reported a position in Genmab in Q2 2020 and held it in 23 quarters.
  • Mark Sheptoff Financial Planning's Genmab position peaked at $124K in Q3 2020.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Mark Sheptoff Financial Planning's 13F filing for Q1 2026, filed 11 May 2026.